PPD downgraded by JP Morgan with a new price target
$PPD
Biotechnology: Commercial Physical & Biological Resarch
Health Care
JP Morgan downgraded PPD from Overweight to Neutral and set a new price target of $48.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 8/5/2021 | $47.50 | Neutral | Credit Suisse |